Ohio mail order litigation dismissed
Plaintiffs "lacked legal standing," according to a ruling by Franklin County Common Pleas Court. Judge Frederick Williams on Dec. 3 ruled that there was "no genuine issue of fact" and that the plaintiffs, the Ohio State Pharmaceutical Association could not demonstrate that they were injured by the defendants, Medco subsidiary National Rx Services, five state retirement systems that had contracted with National, the state attorney general, and the state board of pharmacy. The association had argued that it was illegal for the state board, guided by an attorney general opinion, to permit pharmacists licensed in Ohio to fill out-of-state prescriptions.
You may also be interested in...
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?
Lorbrena is approved as a second-line treatment for ALK-positive NSCLC but Pfizer believes data from the first-line Phase III CROWN study makes the drug a serious competitor to standard of care Alecensa in the first-line setting.
A new analysis of the ADAURA study shows that Tagrisso’s disease-free survival benefits in early stage EGFRm NSCLC are replicated for brain metastases, a common complication with a poor prognosis. Filings and OS data await.